SEL launches trial for autism screening

Moscow-Pullman Daily News

Schweitzer Engineering Laboratories has launched a clinical trial for a handheld device that aims to aid in the earlier detection of autism by measuring atypical pupil light reflexes, which may indicate neural activity in the brain stem. The technology is intended as a diagnostic aid to complement current observational screening methods, not as a standalone diagnostic tool. The trial, expected to run through April 2027, seeks to evaluate the device's performance in a clinical setting and support future regulatory submissions.

Read at Moscow-Pullman Daily News

All articles from 17 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.

Get this news by email

Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.

More to read